Medicine catalog

Search official names, active ingredients, and BDPM codes. Cards show a readable name and form; the exact French source details are available below.

Total in catalog: 20,854 · 7 shown

Commercialized according to BDPM

BAVENCIO 20 mg/ml, concentrate for solution for infusion

Active ingredients: Avelumab

Original BDPM details in French

Official name: BAVENCIO 20 mg/mL, solution à diluer pour perfusion
Active ingredients: AVÉLUMAB
Package description: 1 flacon(s) en verre de 10 ml

CIS 60199966CIP7 5504152CIP13 3400955041528

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

TAKHZYRO 150 mg, solution for injection in a pre-filled syringe

Active ingredients: Lanadelumab

Original BDPM details in French

Official name: TAKHZYRO 150 mg, solution injectable en seringue préremplie
Active ingredients: LANADÉLUMAB
Package description: 1 seringue(s) préremplie(s) en verre de 1 ml

CIS 67650090CIP7 3028030CIP13 3400930280300

View details

Estimated price€17,989.50No current ANSM shortage notice is included

Commercialized according to BDPM

TAKHZYRO 300 mg, solution for injection in a pre-filled syringe

Active ingredients: Lanadelumab

Original BDPM details in French

Official name: TAKHZYRO 300 mg, solution injectable en seringue préremplie
Active ingredients: LANADÉLUMAB
Package description: 1 seringue(s) préremplie(s) en verre de 2 ml

CIS 63473155CIP7 3021260CIP13 3400930212608

View details

Estimated price€17,989.50No current ANSM shortage notice is included

Commercialized according to BDPM

TAKHZYRO 300 mg, solution for injection in a pre-filled pen

Active ingredients: Lanadelumab

Original BDPM details in French

Official name: TAKHZYRO 300 mg, solution injectable en stylo prérempli
Active ingredients: LANADÉLUMAB
Package description: 1 stylo pré-rempli en verre de 2 mL

CIS 61865798CIP7 3031611CIP13 3400930316115

View details

Estimated price€17,989.50No current ANSM shortage notice is included

Commercialized according to BDPM

TEZSPIRE 210 mg, solution for injection in a pre-filled syringe

Active ingredients: Tezepelumab

Original BDPM details in French

Official name: TEZSPIRE 210 mg, solution injectable en seringue préremplie
Active ingredients: TÉZÉPELUMAB
Package description: 1 seringue préremplie en verre de 1,91 mL

CIS 68954908CIP7 3026159CIP13 3400930261590

View details

Estimated price€2,017.62No current ANSM shortage notice is included

Commercialized according to BDPM

TEZSPIRE 210 mg, solution for injection in a pre-filled pen

Active ingredients: Tezepelumab

Original BDPM details in French

Official name: TEZSPIRE 210 mg, solution injectable en stylo prérempli
Active ingredients: TÉZÉPELUMAB
Package description: 1 stylo prérempli en verre de 1,91 mL

CIS 69714595CIP7 3026869CIP13 3400930268698

View details

Estimated price€2,017.62No current ANSM shortage notice is included

Commercialized according to BDPM

SAPHNELO 300 mg, concentrate for solution for infusion

Active ingredients: Anifrolumab

Original BDPM details in French

Official name: SAPHNELO 300 mg, solution à diluer pour perfusion
Active ingredients: ANIFROLUMAB
Package description: 1 flacon(s) en verre de 2 ml

CIS 61365985CIP7 5508736CIP13 3400955087366

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

The displayed price is an estimate. It is not an offer to sell or confirmation of stock. Current catalog version published 4 Nov 2026.